4.915

2.08% 0.105

Bausch Health Companies Inc (BHC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BHC Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$4.81

Aprire:

$4.87

Volume 24 ore:

1.45M

Relative Volume:

0.70

Capitalizzazione di mercato:

$1.84B

Reddito:

$10.53B

Utile/perdita netta:

$-1.23B

Rapporto P/E:

-1.5142

EPS:

-3.246

Flusso di cassa netto:

$949.99M

1 W Prestazione:

-0.41%

1M Prestazione:

-8.57%

6M Prestazione:

-37.85%

1 anno Prestazione:

-28.53%

Intervallo 1D:

$4.85

$5.005

Intervallo di 1 settimana:

$4.74

$5.005

Portata 52W:

$4.565

$8.685

Bausch Health Companies Inc Stock (BHC) Company Profile

Nome

Bausch Health Companies Inc

Settore

Healthcare (1100)

Industria

Drug Manufacturers - Specialty & Generic (86)

Telefono

514-744-6792

Indirizzo

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Dipendente

20,300

Cinguettio

Prossima data di guadagno

2026-07-29

Ultimi documenti SEC

BHC's Discussions on Twitter

Compare BHC vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BHC Bausch Health Companies Inc	4.915	1.80B	10.53B	-1.23B	949.99M	-3.246
TAK Takeda Pharmaceutical Co Adr	16.95	53.37B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.84	42.80B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.58	41.09B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.86	31.62B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	558.90	23.23B	3.17B	1.29B	1.01B	27.09

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Equal Weight
2024-08-02	Downgrade	Piper Sandler	Neutral → Underweight
2024-07-10	Iniziato	Raymond James	Mkt Perform
2023-09-20	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Downgrade	TD Cowen	Outperform → Market Perform
2022-07-29	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-07-29	Downgrade	Truist	Buy → Hold
2022-07-28	Downgrade	JP Morgan	Overweight → Neutral
2022-06-13	Ripresa	JP Morgan	Overweight
2021-03-24	Downgrade	BofA Securities	Neutral → Underperform
2021-02-17	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2021-01-22	Downgrade	Piper Sandler	Overweight → Neutral
2020-09-17	Aggiornamento	BofA Securities	Underperform → Neutral
2020-08-24	Reiterato	H.C. Wainwright	Buy
2020-06-17	Reiterato	H.C. Wainwright	Buy
2020-04-24	Iniziato	Citigroup	Buy
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-01-22	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2019-12-12	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-02	Iniziato	Goldman	Neutral
2019-10-25	Iniziato	Cowen	Outperform
2019-09-12	Iniziato	Guggenheim	Buy
2019-08-15	Aggiornamento	TD Securities	Hold → Buy
2019-07-19	Iniziato	Wolfe Research	Outperform
2019-06-11	Ripresa	Barclays	Overweight
2019-05-13	Aggiornamento	JP Morgan	Underweight → Neutral
2019-03-20	Iniziato	SunTrust	Buy
2019-01-02	Aggiornamento	Piper Jaffray	Neutral → Overweight
2018-11-05	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-09-13	Aggiornamento	Piper Jaffray	Underweight → Neutral

Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

07:05 AM

Bausch Health plans July 29 call for Q2 results and business update - Stock Titan

07:05 AM

07:00 AM

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 - TradingView

07:00 AM

Jul 06, 2026

Bausch Health Continues Specialty Pharma Strategy In 6 July 2026 - Kalkine Media

Jul 06, 2026

Why Did Bausch Health (TSX:BHC) Announce a Board Change? - Kalkine Media

Jul 06, 2026

Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia - Yahoo! Finance Canada

Jul 06, 2026

Jul 03, 2026

Bausch Health Companies (BHC) Posts Modest Gain, Tests Resistance ZoneETF AUM Growth - dars.gov.et

Jul 03, 2026

Jul 02, 2026

Bausch Health (BHC) director granted RSUs in lieu of cash fees - Stock Titan

Jul 02, 2026

Bausch Health (NYSE: BHC) director John Paulson granted 12,677 RSUs as board pay - Stock Titan

Jul 02, 2026

Bausch Health (NYSE: BHC) director granted 6,845 RSUs as board compensation - Stock Titan

Jul 02, 2026

Bausch Health (TSX:BHC) Board Change Follows Director Resignation - Kalkine Media

Jul 02, 2026

Best TSX Healthcare Stocks to Watch for July 2026 - Kalkine Media

Jul 02, 2026

Jul 01, 2026

Michael Goettler Resigns from Bausch Health's Board of Directors - The Globe and Mail

Jul 01, 2026

Director Michael Goettler exits Bausch Health (NYSE: BHC) board - Stock Titan

Jul 01, 2026

Bausch + Lomb survey finds dry eye affects emotional health By Investing.com - Investing.com South Africa

Jul 01, 2026

Jun 29, 2026

Why Is Bausch Health (TSX:BHC) Expanding Beyond the S&P/TSX? - Kalkine Media

Jun 29, 2026

Jun 27, 2026

BVF Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026

Bausch Health (BHC) Drops Nearly 10%: Support Levels in Focus After Sharp DeclineMean Reversion Trade - dars.gov.et

Jun 27, 2026

Price to earnings forward of Bausch Health Companies Inc. – FWB:BVF - TradingView

Jun 26, 2026

Bausch Health Companies Inc. Actuals & Estimates (NYSE:BHC) - TradingView

Jun 26, 2026

Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (FWB:BVF) - TradingView

Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (BOATS:BHC) - TradingView

Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (LSX:A2JQ1X) - TradingView

Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (BIVA:BHC/N) - TradingView

Jun 25, 2026

BHC Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Bausch Health Companies adjusts debt profile, shares react to refinancing step - AD HOC NEWS

Jun 25, 2026

Price to earnings forward of Bausch Health Companies Inc. – BOATS:BHC - TradingView

Jun 25, 2026

Jun 23, 2026